ANALYSIS OF EPIDEMIOLOGICAL FEATURES OF COVID-19 IN PAVLODAR REGION
Introduction: Coronavirus infection (COVID-19), first reported at the end of 2019, which has spilled over into a worldwide pandemic and has affected all aspects of our modern lives. The aim is to study and analyze the epidemiological features of COVID-19 in the Pavlodar region. Materials and methods: Study design is a descriptive retrospective study analysis. The data were obtained from official sources of the Republican Center for e-Health of the Ministry of Health of the Republic of Kazakhstan. The study includes patients from June 30, 2020 to October 31, 2021 who received outpatient and inpatient treatment for coronavirus infection in medical institutions of the Pavlodar region. Study materials – uploading reports from the Republican Center for e-Health of the Ministry of Health of the Republic of Kazakhstan. Results: This article presents epidemiological data on the incidence of coronavirus infection in the population of Pavlodar region. The number of detected cases of COVID-19 from June 30, 2020 to October 31, 2021 was 29,443. Distribution of patients by sex predominated women - 17,831 (60.56%), than men - 11,612 (39.44%). The majority of cases were in the age group from 61 to 70 years old, with a male to female ratio of 1:1.54. Statistical significance was found between duration of stay and type of inpatient care (p<0.001, VS-MPR*=2.135×10+22). Conclusion: The study showed that the number of women who fell ill prevailed over the number of men who fell ill, although the number of deaths among men prevailed over the number of deaths among women. In the study, there was no significant difference in the duration of stay for men and women in home care, compared to patients under 24-hour observation.
Yedil D. Omarbekov1, https://orcid.org/0000-0001-5736-4866 Sholpan Е. Тоkanova1, http://orcid.org/0000-0003-0304-4976 Assel Zh. Baibussinova1, http://orcid.org/0000-0003-3447-6245 Erlan A. Ospanov1, http://orcid.org/0000-0002-1344-5477 Ainur S. Krykpayeva1, http://orcid.org/0000-0001-7701-9832 1 NCJSC «Semey Medical University», Semey, Republic of Kazakhstan.
1. Новости Sputnik Казахстан. Два года пандемии COVID-19: хронология событий [Электронный ресурс] https://ru.sputnik.kz/20220311/dva-goda-pandemii-covid-19-khronologiya-sobytiy-23443376.html (дата обращения 17.01.2023). 2. Обзорно-аналитический портал Strategy 2050. Год пандемии: как Казахстан справлялся с коронавирусом [Электронный ресурс] https://strategy2050.kz/ru/news/god-pandemii-kak-kazakhstan-spravlyalsya-s-koronavirusom-/ (дата обращения 17.01.2023). 3. Ситуация с коронавирусом официально [Электронный ресурс] https://www.coronavirus2020.kz/ (дата обращения 17.01.2023). 4. Ahrenfeldt L.J., Otavova M., Christensen K., Lindahl-Jacobsen R. Sex and age differences in COVID-19 mortality in Europe // Wien Klin Wochenschr. 2021 Apr. 133(7-8):393-398. doi: 10.1007/s00508-020-01793-9. Epub 2020 Dec 22. PMID: 33351155; PMCID: PMC7755064. 5. Bauer P., Brugger J., König F. et al. An international comparison of age and sex dependency of COVID-19 deaths in 2020: a descriptive analysis // Sci Rep. 2021. 11. 19143. https://doi.org/10.1038/s41598-021-97711-8. 6. Bienvenu L.A., Noonan J., Wang X., Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020 Dec 1. 116(14):2197-2206. doi: 10.1093/cvr/cvaa284. PMID: 33063089; PMCID: PMC7665363. 7. Chams N., Chams S., Badran R., Shams A., Araji A., Raad M., Mukhopadhyay S., Stroberg E., Duval E.J., Barton L.M., Hajj Hussein I. COVID-19: A Multidisciplinary Review // Front Public Health. 2020 Jul 29. 8:383. doi: 10.3389/fpubh.2020.00383. 8. Chanana N., Palmo T., Sharma K., Kumar R., Graham B.B., Pasha Q. Sex-derived attributes contributing to SARS-CoV-2 mortality // Am J Physiol Endocrinol Metab. 2020 Sep 1. 319(3):E562-E567. doi: 10.1152/ajpendo.00295.2020. Epub 2020 Jul 29. PMID: 32726128; PMCID: PMC7473885. 9. Chiam T., Subedi K., Chen D., Best E., Bianco F.B., Dobler G., Papas M. Hospital length of stay among COVID-19-positive patients // J Clin Transl Res. 2021 Jun 5;7(3):377-385. PMID: 34239994. PMCID: PMC8259605. 10. Gebhard C., Regitz-Zagrosek V., Neuhauser H.K., Morgan R, Klein S.L. Impact of sex and gender on COVID-19 outcomes in Europe // Biol Sex Differ. 2020. 11(1):29. doi: 10.1186/s13293-020-00304-9. 11. Global Health 50/50. The COVID-19 Sex‐Disaggregated Data Tracker. https://globalhealth5050.org/the-sex-gender-and-covid-19-project/ (Accessed September 20, 2022). 12. Jin J.M., Bai P., He W., Wu F. et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality // Front Public Health. 2020 Apr 29. 8:152. doi: 10.3389/fpubh.2020.00152. PMID: 32411652; PMCID: PMC7201103. 13. Korean Society of Infectious Diseases; Korean Society of Pediatric Infectious Diseases; Korean Society of Epidemiology; Korean Society for Antimicrobial Therapy; Korean Society for Healthcare-associated Infection Control and Prevention; Korea Centers for Disease Control and Prevention. Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020 // J Korean Med Sci. 2020 Mar 16. 35(10):e112. doi: 10.3346/jkms.2020.35.e112. PMID: 32174069; PMCID: PMC7073313. 14. Kremer H.J., Thurner W. Age Dependence in COVID-19 Mortality in Germany // Dtsch Arztebl Int. 2020 Jun 19. 117(25):432-433. doi: 10.3238/arztebl.2020.0432. PMID: 32885782; PMCID: PMC7490456. 15. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K.S., et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia // N Engl J Med. 2020 Mar 26. 382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29. PMID: 31995857; PMCID: PMC7121484. 16. O'Brien J., Du K.Y., Peng C. Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age // J Ovarian Res. 2020 Nov 24. 13(1):137. doi: 10.1186/s13048-020-00734-4. Erratum in: J Ovarian Res. 2021 Apr 27. 14(1):58. PMID: 33234144; PMCID: PMC7684854. 17. Takahashi T., Ellingson M.K., Wong P. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes // Nature. 588, 315–320 (2020). https://doi.org/10.1038/s41586-020-2700-3. 18. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020. China CDC Wkly. 2020 Feb 21. 2(8):113-122. PMID: 34594836; PMCID: PMC8392929. 19. Tomáš Sobotka, Zuzanna Brzozowska, Raya Muttarak, Kryštof Zeman, Vanessa di Lego Age, gender and COVID-19 infections // med Rxiv 2020.05.24.20111765; doi: https://doi.org/10.1101/2020.05.24.20111765. 20. Zhuo Wang, John S. Ji, Yang Liu, Runyou Liu, Yuxin Zha, Xiaoyu Chang, Lun Zhang et al. Survival analysis of hospital length of stay of novel coronavirus (COVID-19) pneumonia patients in Sichuan // China Xianping Wumed Rxiv 2020.04.07.20057299. Now published in PLOS ONE doi: 10.1371/journal.pone.0261216.
Количество просмотров: 379

Ключевые слова:

Категория статей: Актуальная тема COVID-19

Библиографическая ссылка

Omarbekov Ye.D., Тоkanova Sh.Е., Baibussinova A.Zh., Ospanov E.A., Krykpayeva A.S. Analysis of epidemiological features of COVID-19 in Pavlodar region // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 1, pp. 26-32. doi 10.34689/SH.2023.25.1.003

Авторизируйтесь для отправки комментариев